Clinical trial
Prospective Study of Endometrial Cancer Treatment in Relation to Molecular Markers in Curettage Specimens.
NCT00598845 is registered in ClinicalTrials.gov with University of Bergen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Study of Endometrial Cancer Treatment in Relation to Molecular Markers in Curettage Specimens.
- Lead sponsor
- University of Bergen
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- April 30, 2001
- Completion date
- December 31, 2017
- Enrollment
- 1,000 (estimated)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.